Loading…
← CockpitCompetitor Analysis › MAXHEALTH.NS Max Healthcare InstituteOpen in the cockpit ↗

Max Healthcare InstituteMAXHEALTH.NSCompetitor analysis, valuation and peers

India · INR·Pharma & Healthcare›Hospital/Nursing Management

North India-focused private hospital chain concentrated in Delhi-NCR and surrounding states.

≈ A regional HCA Healthcare for North IndiaMomentum strong 69
Mkt cap
$10.6B
US dollars, full cap
Free float
70%
of shares outstanding
$/day
$38.6M
20-day average traded
Fwd P/E
55.2×
forward earnings
ROIC−WACC
-3.6 pp
WACC 13.4%
Hurdle
+18 pp
Req g minus delivered
Next earnings
78 days
4 Feb 2027
Close · INR₹1,023
1D-0.8%
1W+10.2%
1M+23.2%
3M+0.8%
6M-4.3%
YTD-2.1%
1Y-7.3%
ATR %2.8%
Beta0.65
52w lowhigh13.7% off high

What Max Healthcare Institute does

North India-focused private hospital chain concentrated in Delhi-NCR and surrounding states.

Earns per patient treated, so income depends on how many beds are occupied and the revenue each occupied bed brings, which rises with complex surgery, cancer care and transplants. The cost of building or buying hospitals comes upfront, before the beds fill.

In one line: A regional HCA Healthcare for North India.

Products and services

  • Hospital / tertiary care services
  • Diagnostics
  • Home healthcare

Customers

  • North India patients (Delhi-NCR, Punjab, UP)
  • Corporate/insurance-covered patients
  • Medical tourists

Where it sits in the supply chain

  • Private healthcare delivery
  • Multi-specialty hospital network
  • Tertiary & quaternary care hospitals…

What could go right

  • Rising healthcare spending in North India
  • Bed-capacity expansion driving volume growth

What could go wrong

  • Geographic concentration in North India
  • Capital-intensive expansion, regulatory price caps

Moat: narrow (brand, scale, installed base). Leading private-hospital brand and bed capacity concentrated in the affluent Delhi-NCR catchment.

Headquarters: New Delhi, India · Founded: 2000 · Employees: 31,127

Named competitors

Max Healthcare Institute at a glance

Size Max Healthcare Institute (MAXHEALTH.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $10.6B, the 118th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹1,023 on 18 Nov 2026.

Performance Over six months the shares fell 4.3%, against +14.6% for the median peer and +3.8% for the India market (cap-weighted) — 2nd lowest of 15 in its peer set.

Growth Revenue grew 15.2% over the last twelve months (peer median +11.0%); the operating margin is 21.3% (peer median 12.7%).

Valuation It trades at 55.2× forward earnings against a peer median of 41.3× (5th most expensive of 15).

Price implies For today's price to make sense, revenue must grow about 45% a year for seven years (Req g). Recent delivered growth is +27%, so the hurdle is +18 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 3.6 points below its cost of capital (13.4% WACC).

Next results Next results expected around 4 Feb 2027 (exchange calendar; dates can move).

Relative performance

8010012021 May 202621 Aug 202618 Nov 2026Peer median 115MAXHEALTH.NS 95
Six months, rebased to 100: Max Healthcare Institute against the median of its 15 peers (local-currency closes).

Max Healthcare Institute financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹91.5B₹83.5B₹70.1B₹53.9B₹45.5B
Revenue growth—+19%+30%+18%—
Gross profit₹32.6B₹43.0B₹36.1B₹17.5B₹14.1B
EBITDA₹24.5B₹22.8B₹19.1B₹15.2B₹12.6B
Net income₹13.8B₹14.4B₹10.8B₹10.6B₹11.0B
Free cash flown/a₹948M₹4.93B₹3.17B₹9.05B
Capital expendituren/a₹14.8B₹9.44B₹7.86B₹3.36B
Total debt₹38.0B₹34.8B₹30.1B₹15.1B₹9.08B

Quarterly statements and history in the cockpit →

Max Healthcare Institute competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%+100%0%+50%UHSAPOLLOHOSPRHCPACSCHEASTERDMFORTISTHCNHSGRYFRENHCMAXHEALTH.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Max Healthcare Institute is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%25×50×75×UHSMANIPALHOSAPOLLOHOSPRHCPACSCHEASTERDMFORTISNHMEDANTASGRYKIMSMAXHEALTH.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Max Healthcare Institute is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%UHSMANIPALHOSAPOLLOHOSPRHCPACSCHEASTERDMFORTISTHCNHSGRYFRENHCMAXHEALTH.NSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Max Healthcare Institute is the large dot.

Max Healthcare Institute competitors and peer comparison

Head to head with its named competitors (MAXHEALTH.NS vs APOLLOHOSP.NS vs FORTIS.NS vs MANIPALHOS.NS)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Max Healthcare Institute MAXHEALTH.NS$10.6B-4%+15%21%55.2×45.3%
Apollo Hospitals Enterprise APOLLOHOSP.NS$13.6B+10%+19%12%51.0×33.3%
Fortis Healthcare FORTIS.NS$6.40B-17%+18%17%48.5×42.5%
Manipal Health Enterprises MANIPALHOS.NS$9.69Bn/a+25%19%66.5×32.9%

How Max Healthcare Institute compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Max Healthcare Institute against its 15 peers (data as of 18 Nov 2026)
MeasureMAXHEALTH.NSPeer medianRank in peer set
1-month return+23.2%+8.6%2nd highest of 16
6-month return-4.3%+14.6%2nd lowest of 15
Distance from 52-week high-13.7%-10.0%6th lowest of 16
Revenue growth (TTM)+15.2%+11.0%8th highest of 16
Operating margin21.3%12.7%highest of 16
Forward P/E55.2×41.3×5th most expensive of 15
Growth the price implies (Req g, 7 yrs)45.3%14.0%2nd most demanding of 14
Growth delivered (Del g)+27.2%+9.7%3rd highest of 14
Hurdle (Req g minus delivered)+18.1 pp+4.1 pp3rd most demanding of 14
ROIC minus cost of capital-3.6 pp-1.2 pp6th lowest of 16
EV / EBITDA41.9×21.6×2nd most expensive of 15
Net debt / EBITDA1.3×2.3×5th least indebted of 16

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Max Healthcare Institute MAXHEALTH.NSIndia$10.6B-4%+15%21%55.2×45.3%+27.2%
Universal Health Services UHSUnited States$10.7B+13%+8%11%8.3×-1.8%+8.5%
Manipal Health Enterprises MANIPALHOS.NSIndia$9.69Bn/a+25%19%66.5×32.9%+28.8%
Apollo Hospitals Enterprise APOLLOHOSP.NSIndia$13.6B+10%+19%12%51.0×33.3%+19.0%
Ramsay Health Care RHC.AXAustralia$8.31B+41%+4%5%31.4×14.0%+8.3%
PACS PACSUnited States$7.35B+25%+11%8%17.5×7.5%+29.7%
Chemed CHEUnited States$7.12B+24%+5%14%20.2×3.3%+4.0%
Aster DM Quality Care ASTERDM.NSIndia$6.83B-2%+50%16%63.5×48.6%-11.6%
Fortis Healthcare FORTIS.NSIndia$6.40B-17%+18%17%48.5×42.5%+17.9%
Tenet Healthcare THCUnited States$21.6B+45%+6%17%13.4×-1.4%+3.9%
Narayana Hrudayalaya NH.NSIndia$4.13B0%+71%13%34.2×31.2%+25.0%
Global Health MEDANTA.NSIndia$4.13B+16%+26%17%50.4×n/an/a
Surgery Partners SGRYUnited States$3.53B+100%+2%13%77.2×15.6%+12.2%
Fresenius SE & Co. KGaA FRE.DEGermany$32.7B+41%+7%10%14.7×7.0%-8.8%
Krishna Institute of Medical Sciences KIMS.NSIndia$3.41B+2%+35%11%81.9×n/an/a
National HealthCare NHCUnited States$3.16B+1%+6%0%n/a6.4%+9.7%

Questions

Who are Max Healthcare Institute's main competitors?
Named competitors: Apollo Hospitals Enterprise (APOLLOHOSP.NS), Fortis Healthcare (FORTIS.NS), Manipal Health Enterprises (MANIPALHOS.NS), Medanta (private or unlisted). The cockpit's measured peer set (industry) also includes Universal Health Services (UHS), Manipal Health Enterprises (MANIPALHOS.NS), Apollo Hospitals Enterprise (APOLLOHOSP.NS), Ramsay Health Care (RHC.AX), PACS (PACS), Chemed (CHE).
Is Max Healthcare Institute expensive compared with its peers?
On forward p/e it trades at 55.2× against a peer median of 41.3×, 5th most expensive of 15 in its peer set. For today's price to make sense, revenue must grow about 45% a year for seven years (Req g). Recent delivered growth is +27%, so the hurdle is +18 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Max Healthcare Institute stock performed?
Over six months to 18 Nov 2026 the shares returned -4.3% against +14.6% for the median peer; over one year -7.3%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.